Overview

Efficacy of Prednisone In the Treatment of Ocular Myasthenia

Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and tolerability of prednisone in patients diagnosed with ocular myasthenia. Funding Source - FDA OOPD
Phase:
Phase 3
Details
Lead Sponsor:
Michael Benatar
Collaborators:
University of Miami
University of Rochester
Treatments:
Prednisone
Pyridostigmine Bromide